Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Koninklijke Philips N.V. or ResMed Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Koninklijke Philips N.V. and ResMed Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Koninklijke Philips N.V. and ResMed Inc.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Latest Health Care Equipment & Supplies and Koninklijke Philips N.V., ResMed Inc. Stock News

As of September 8, 2026, Koninklijke Philips N.V. had a $24.8 billion market capitalization, compared to the Health Care Equipment & Supplies median of $415.8 million. Koninklijke Philips N.V.’s stock is down 7.6% in 2026, down 5.9% in the previous five trading days and down 9.45% in the past year.

Currently, Koninklijke Philips N.V.’s price-earnings ratio is 19.4. Koninklijke Philips N.V.’s trailing 12-month revenue is $20.2 billion with a 6.3% net profit margin. Year-over-year quarterly sales growth most recently was -2.2%. Analysts expect adjusted earnings to reach $1.763 per share for the current fiscal year. Koninklijke Philips N.V. does not currently pay a dividend.

As of September 8, 2026, ResMed Inc. had a $31.6 billion market cap, putting it in the 90th percentile of all stocks. ResMed Inc.’s stock is down 8.7% in 2026, down 4.9% in the previous five trading days and down 20.21% in the past year.

Currently, ResMed Inc.’s price-earnings ratio is 21.2. ResMed Inc.’s trailing 12-month revenue is $5.7 billion with a 26.9% net profit margin. Year-over-year quarterly sales growth most recently was 8.6%. Analysts expect adjusted earnings to reach $12.081 per share for the current fiscal year. ResMed Inc. currently has a 1.2% dividend yield.

How We Compare Koninklijke Philips N.V. and ResMed Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Koninklijke Philips N.V. and ResMed Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Koninklijke Philips N.V. and ResMed Inc.’s Quality Grades

Company	Ticker	Quality
Koninklijke Philips N.V.	PHG	A
ResMed Inc.	RMD	A

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

Koninklijke Philips N.V. has a Quality Score of 94, which is Very Strong. ResMed Inc. has a Quality Score of 95, which is Very Strong.

The Quality Grade Winner: It’s a Tie!

Looking at the Quality Grade breakdown above, both Koninklijke Philips N.V. and ResMed Inc. have a grade of A. For investors who focus solely on a company’s overall quality, you will need to conduct further research into both companies to see if they are a good fit for your portfolio. As a good rule of thumb, you should always analyze multiple factors based on a wide range of metrics before choosing a company to invest in.

Koninklijke Philips N.V. and ResMed Inc.’s Momentum Grades

Company	Ticker	Momentum
Koninklijke Philips N.V.	PHG	D
ResMed Inc.	RMD	D

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Koninklijke Philips N.V. has a Momentum Score of 32, which is Weak. ResMed Inc. has a Momentum Score of 35, which is Weak.

The Momentum Stock Winner: No Clear Winner

Neither Koninklijke Philips N.V. or ResMed Inc. has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Koninklijke Philips N.V. or ResMed Inc. is the better investment when it comes to momentum.

Koninklijke Philips N.V. and ResMed Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Koninklijke Philips N.V.	PHG	D
ResMed Inc.	RMD	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Koninklijke Philips N.V. has a Earnings Estimate Score of 22, which is Negative. ResMed Inc. has a Earnings Estimate Score of 42, which is Neutral.

The Earnings Estimate Revisions Stock Winner: No Clear Winner

Neither Koninklijke Philips N.V. or ResMed Inc. has an Earnings Estimate Revisions Grade that could be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Koninklijke Philips N.V. or ResMed Inc. is the better investment when it comes to estimate revisions.

Other Koninklijke Philips N.V. and ResMed Inc. Grades

In addition to Quality, Estimate Revisions and Momentum, A+ Investor also provides grades for Value and Growth.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Koninklijke Philips N.V. and ResMed Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Koninklijke Philips N.V. or ResMed Inc. Stock?

Overall, Koninklijke Philips N.V. stock has a Momentum Score of 32, Estimate Revisions Score of 22 and Quality Score of 94.

ResMed Inc. stock has a Momentum Score of 35, Estimate Revisions Score of 42 and Quality Score of 95.

Comparing Koninklijke Philips N.V. and ResMed Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.